Atlas Trials

(Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast Cancer

Clinical trial NCT02627703 · UNKNOWN

Trial details

NCT number
NCT02627703
Sponsor
British Columbia Cancer Agency
Status
UNKNOWN
Study type
OBSERVATIONAL
Breast Cancer
Start date
2010-05-01
Primary completion
2017-12-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.